| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877062 | The Annals of Thoracic Surgery | 2012 | 8 Pages |
Abstract
Pediatric MVR can be performed with low initial mortality but should be reserved for medical and reconstruction failure because reoperation, valve-related complications, and late mortality are high. Bileaflet prostheses larger than 23 mm have the lowest reoperation risk. Ross MVR may offer select patients a durable tissue valve without lifelong anticoagulation and its associated complications.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
John W. MD, Andrew C. MD, Mark MD, PhD, Osama MD, Mark D. MD, Mark W. MD,